mifepristone has been researched along with Dementia Praecox in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbero, JD; Bioque, M; Cobo, J; García-Rizo, C; González-Rodríguez, A; Huerta-Ramos, E; Labad, J; Monreal, JA; Soria, V; Tost, M; Usall, J | 1 |
Ferrier, IN; Gallagher, P; Smith, MS; Watson, S; Young, AH | 1 |
Ferrier, IN; Gallagher, P; Mackin, P; Watson, S; Young, AH | 1 |
Elizabeth Dye, C; Gallagher, P; Nicol Ferrier, I; Watson, S; Young, AH | 1 |
1 review(s) available for mifepristone and Dementia Praecox
Article | Year |
---|---|
Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis.
Topics: Affective Disorders, Psychotic; Bipolar Disorder; Cognition Disorders; Cognitive Dysfunction; Depressive Disorder, Major; Female; Gonadal Steroid Hormones; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Mifepristone; Mood Disorders; Pituitary-Adrenal System; Pregnenolone; Raloxifene Hydrochloride; Schizophrenia | 2018 |
3 trial(s) available for mifepristone and Dementia Praecox
Article | Year |
---|---|
Effects of adjunctive mifepristone (RU-486) administration on neurocognitive function and symptoms in schizophrenia.
Topics: Adult; Analysis of Variance; Antidepressive Agents; Antipsychotic Agents; Cholinergic Antagonists; Cognition; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Hormone Antagonists; Humans; Hydrocortisone; Memory; Middle Aged; Mifepristone; Psychiatric Status Rating Scales; Psychomotor Performance; Receptors, Glucocorticoid; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2005 |
Changes in brain-derived neurotrophic factor following treatment with mifepristone in bipolar disorder and schizophrenia.
Topics: Adult; Affect; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Cognition; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Hormone Antagonists; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Middle Aged; Mifepristone; Pituitary-Adrenal System; Schizophrenia | 2007 |
Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia.
Topics: Bipolar Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Glucocorticoids; Hormone Antagonists; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Mifepristone; Pituitary-Adrenal System; Placebos; Psychiatric Status Rating Scales; Receptors, Glucocorticoid; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2008 |